GO
Loading...

Health Care Equipment and Supplies

More

  • Early Glance: Medical Devices companies Monday, 23 Feb 2015 | 10:40 AM ET

    Allergan fell$. 02 or percent, to $233.98. Boston Scientific Corp. fell$. 01 or. 1 percent, to $16.46. Johnson& Johnson fell$. 01 or percent, to $100.25.

  • Final Glance: Medical Devices companies Friday, 20 Feb 2015 | 6:00 PM ET

    Allergan rose $2.88 or 1.2 percent, to $234.00. Baxter International Inc. rose$. 48 or. 7 percent, to $67.90. Boston Scientific Corp. rose$. 02 or. 1 percent, to $16.47.

  • Midday Glance: Medical Devices companies Friday, 20 Feb 2015 | 1:36 PM ET

    Allergan rose $3.00 or 1.3 percent, to $234.12. Baxter International Inc. fell$. 75 or 1.1 percent, to $66.68. Boston Scientific Corp. fell$. 07 or. 4 percent, to $16.38.

  • Early Glance: Medical Devices companies Friday, 20 Feb 2015 | 10:50 AM ET

    Allergan rose$. 34 or. 1 percent, to $231.46. Baxter International Inc. fell $1.29 or 1.9 percent, to $66.13. Boston Scientific Corp. fell$. 13 or. 8 percent, to $16.32.

  • LOS ANGELES— An 18- year-old student is one of the seven people infected by a "superbug" outbreak tied to contaminated medical instruments at a Los Angeles hospital, and he is struggling to avoid becoming the third to die, his attorney said. The young man as spent nearly three months in the hospital and is in grave condition after being infected with a potentially...

  • Final Glance: Medical Devices companies Thursday, 19 Feb 2015 | 6:03 PM ET

    Allergan rose $1.62 or. 7 percent, to $231.12. Baxter International Inc. fell$. 98 or 1.4 percent, to $67.42. Boston Scientific Corp. fell$. 23 or 1.4 percent, to $16.45.

  • Midday Glance: Medical Devices companies Thursday, 19 Feb 2015 | 1:28 PM ET

    Allergan rose $1.10 or. 5 percent, to $230.60. Baxter International Inc. fell$. 91 or 1.3 percent, to $67.49. Boston Scientific Corp. fell$. 30 or 1.8 percent, to $16.38.

  • Early Glance: Medical Devices companies Thursday, 19 Feb 2015 | 10:51 AM ET

    Allergan rose $1.13 or. 5 percent, to $230.63. Baxter International Inc. fell$. 87 or 1.3 percent, to $67.53. Johnson& Johnson fell$. 08 or. 1 percent, to $99.89.

  • LOS ANGELES— A "superbug" outbreak suspected in the deaths of two Los Angeles hospital patients is raising disturbing questions about the design of a hard-to-clean medical instrument used on more than half a million people in the U.S. every year. At least seven people— two of whom died— have been infected with a potentially lethal, antibiotic-resistant strain of...

  • Final Glance: Medical Devices companies Wednesday, 18 Feb 2015 | 6:30 PM ET

    Allergan fell$. 65 or. 3 percent, to $229.50. Baxter International Inc. fell $1.39 or 2.0 percent, to $68.40. Boston Scientific Corp. rose $1.84 or 12.4 percent, to $16.68.

  • Boston Scientific and Fossil are big market movers Wednesday, 18 Feb 2015 | 4:31 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:. Boston Scientific Corp., up $1.84 to $16.68. The medical device maker will pay $600 million as part of a settlement with Johnson& Johnson over the 2006 purchase of Guidant Corp..

  • Midday Glance: Medical Devices companies Wednesday, 18 Feb 2015 | 1:18 PM ET

    Allergan fell $2.74 or 1.2 percent, to $227.41. Baxter International Inc. fell $1.81 or 2.6 percent, to $67.98. Boston Scientific Corp. rose $1.66 or 11.2 percent, to $16.50.

  • Early Glance: Medical Devices companies Wednesday, 18 Feb 2015 | 10:54 AM ET

    Allergan fell $1.80 or. 8 percent, to $228.35. Baxter International Inc. fell $1.02 or 1.5 percent, to $68.77. Boston Scientific Corp. rose $1.53 or 10.3 percent, to $16.37.

  • Feb 17- Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson& Johnson to settle a long-running lawsuit over Boston Scientific's 2005 acquisition of rival Guidant. J&J had sought more than $7 billion in damages after it lost a bidding war to Boston Scientific following an initial deal to buy Guidant for $21.5...

  • Feb 17- Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson& Johnson to settle a long-running breach of merger lawsuit over Boston Scientific's 2005 acquisition of rival Guidant. J&J, which agreed to permanently dismiss its action without acknowledgment of liability by Guidant, had sought more than $7...

  • Feb 17- Medical device maker Medtronic Plc reported a better-than-expected quarterly profit, helped mainly by increased sales in its cardiac and vascular business, its largest. With sales of $2.22 billion in the third quarter ended Jan. 23, the business accounted for a little over half of overall sales. The company, which completed its acquisition of Ireland-...

  • Medtronic profit rises on higher cardiac device sales Tuesday, 17 Feb 2015 | 7:36 AM ET

    Feb 17- Medical device maker Medtronic Plc reported a 28 percent rise quarterly profit, helped mainly by increased sales in its cardiac and vascular business, its largest. The company, which completed its acquisition of Ireland- based Covidien Plc in January, said its net profit rose to $977 million, or 98 cents per share, for the third quarter ended Jan. 23, from $762...

  • NEW YORK/ BOSTON, Feb 11- Security experts are warning healthcare and insurance companies that 2015 will be the "Year of the Healthcare Hack," as cybercriminals are increasingly attracted to troves of personal information held by U.S. insurers and hospitals that command high prices on the underground market. "People feel that this will be the year of medical...

  • U.S. challenges China export subsidy program Wednesday, 11 Feb 2015 | 9:08 AM ET

    WASHINGTON, Feb 11- The United States on Wednesday challenged a Chinese export subsidy program for products including textiles, medical products and agriculture, alleging the support was illegal under international trade law. There are already 24 disputes before the WTO involving the United States and China, 15 of them brought by the United States.

  • UPDATE 2-Boston Scientific profit beats Street by a cent Wednesday, 4 Feb 2015 | 12:00 PM ET

    *4th- qtr adj/shr $0.22 vs est $0.21. Feb 4- Boston Scientific Corp's adjusted quarterly profit edged past the average analyst estimate and the medical device maker reported a growth in sales for the fifth straight quarter, helped by continued demand for its heart devices. Boston Scientific's sales growth and improving margin have been encouraging in the...